Study of Immunotherapy and Intestinal Flora Changes in Patients with Liver Cancer

Hepatocellular carcinoma (HCC) is one of the common major malignancies worldwide and has third highest mortality rate any malignancy. The current field treatment for hepatocellular multidisciplinary in involvement a combination therapeutic approaches, among which immunotherapy modality advanced carcinoma. This review provides new ideas developing regimens improving efficacy patients with liver cancer by summarising progress intestinal flora cancer.